Kovitz Investment Group Partners, LLC Amgen Inc Transaction History

Kovitz Investment Group Partners, LLC

$15 Billion
Q3 2024

A detailed history of Kovitz Investment Group Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 93,668 shares of AMGN stock, worth $24.9 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

93,668

Previous 67,862 38.03%

Holding current value

$24.9 Million

Previous $21.2 Million 42.34%

% of portfolio

0.2%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $7.98 Million - $8.71 Million	25,806 Added 38.03%	93,668 $30.2 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $171,838 - $208,828	654 Added 0.97%	67,862 $21.2 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $6.73 Million - $8.12 Million	25,025 Added 59.32%	67,208 $19.1 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $351,076 - $396,055	-1,373 Reduced 3.15%	42,183 $12.1 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $255,820 - $317,608	-1,170 Reduced 2.62%	43,556 $11.7 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $198,414 - $234,620	-926 Reduced 2.03%	44,726 $9.93 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $49,673 - $60,544	220 Added 0.48%	45,652 $11 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $756,944 - $961,788	-3,305 Reduced 6.78%	45,432 $11.9 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $163,631 - $184,546	-729 Reduced 1.47%	48,737 $11 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $63,906 - $71,116	277 Added 0.56%	49,466 $12 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $225,628 - $249,604	1,029 Added 2.14%	49,189 $11.9 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $2,983 - $3,414	15 Added 0.03%	48,160 $11.1 Million
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $10,825 - $12,683	-51 Reduced 0.11%	48,145 $10.2 Million
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $466,926 - $518,020	-1,999 Reduced 3.98%	48,196 $11.7 Million
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $451,586 - $526,251	2,035 Added 4.23%	50,195 $12.5 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $493,562 - $587,745	-2,281 Reduced 4.52%	48,160 $11.1 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $152,053 - $169,095	-648 Reduced 1.27%	50,441 $12.8 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $494,327 - $606,607	-2,499 Reduced 4.66%	51,089 $12.1 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $355,003 - $470,831	-1,948 Reduced 3.51%	53,588 $10.9 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $240,296 - $308,864	-1,270 Reduced 2.24%	55,536 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $141,551 - $169,608	-813 Reduced 1.41%	56,806 $11 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $417,083 - $488,915	-2,502 Reduced 4.16%	57,619 $10.6 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $159,708 - $180,026	883 Added 1.49%	60,121 $11.4 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $10.3 Million - $12 Million	57,668 Added 3673.12%	59,238 $11.5 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $10,190 - $11,488	55 Added 3.63%	1,570 $325,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $49,815 - $55,953	-300 Reduced 16.53%	1,515 $280,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $221,614 - $258,984	-1,308 Reduced 41.88%	1,815 $309,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $42,197 - $47,147	250 Added 8.7%	3,123 $543,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $480,624 - $548,743	2,873	2,873 $536,000

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.

Account

Kovitz Investment Group Partners, LLC Amgen Inc Transaction History